353 related articles for article (PubMed ID: 33413202)
1. The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo.
Grimes MM; Kenney SR; Dominguez DR; Brayer KJ; Guo Y; Wandinger-Ness A; Hudson LG
BMC Cancer; 2021 Jan; 21(1):40. PubMed ID: 33413202
[TBL] [Abstract][Full Text] [Related]
2. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
[TBL] [Abstract][Full Text] [Related]
3. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases.
Oprea TI; Sklar LA; Agola JO; Guo Y; Silberberg M; Roxby J; Vestling A; Romero E; Surviladze Z; Murray-Krezan C; Waller A; Ursu O; Hudson LG; Wandinger-Ness A
PLoS One; 2015; 10(11):e0142182. PubMed ID: 26558612
[TBL] [Abstract][Full Text] [Related]
4. A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.
Guo Y; Kenney SR; Cook L; Adams SF; Rutledge T; Romero E; Oprea TI; Sklar LA; Bedrick E; Wiggins CL; Kang H; Lomo L; Muller CY; Wandinger-Ness A; Hudson LG
Clin Cancer Res; 2015 Nov; 21(22):5064-72. PubMed ID: 26071482
[TBL] [Abstract][Full Text] [Related]
5. Dual Actions of Ketorolac in Metastatic Ovarian Cancer.
Hudson LG; Cook LS; Grimes MM; Muller CY; Adams SF; Wandinger-Ness A
Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31344967
[TBL] [Abstract][Full Text] [Related]
6. The R-Enantiomer of Ketorolac Delays Mammary Tumor Development in Mouse Mammary Tumor Virus-Polyoma Middle T Antigen (MMTV-PyMT) Mice.
Peretti AS; Dominguez D; Grimes MM; Hathaway HJ; Prossnitz ER; Rivera MR; Wandinger-Ness A; Kusewitt DF; Hudson LG
Am J Pathol; 2018 Feb; 188(2):515-524. PubMed ID: 29169987
[TBL] [Abstract][Full Text] [Related]
7. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
[TBL] [Abstract][Full Text] [Related]
8. Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma.
Sonawane V; Ghosalkar J; Achrekar S; Joshi K
Sci Rep; 2023 Apr; 13(1):5659. PubMed ID: 37024613
[TBL] [Abstract][Full Text] [Related]
9. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
[TBL] [Abstract][Full Text] [Related]
10. Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma.
Kumar A; Al-Sammarraie N; DiPette DJ; Singh US
Oncotarget; 2014 Nov; 5(22):11709-22. PubMed ID: 25365944
[TBL] [Abstract][Full Text] [Related]
11. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
[TBL] [Abstract][Full Text] [Related]
12. Botulinum Toxin A Upregulates Rac1, Cdc42, and RhoA Gene Expression in a Dose-Dependent Manner: In Vivo and in Vitro Study.
Park TH; Park JH; Chang CH; Rah DK
J Craniofac Surg; 2016 Mar; 27(2):516-20. PubMed ID: 26963302
[TBL] [Abstract][Full Text] [Related]
13. The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
Mao W; Peters HL; Sutton MN; Orozco AF; Pang L; Yang H; Lu Z; Bast RC
Cancer; 2019 Apr; 125(8):1267-1280. PubMed ID: 30620384
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
15. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation.
Debidda M; Wang L; Zang H; Poli V; Zheng Y
J Biol Chem; 2005 Apr; 280(17):17275-85. PubMed ID: 15705584
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
17. Methylated dialkylphosphate metabolites of the organophosphate pesticide malathion modify actin cytoskeleton arrangement and cell migration via activation of Rho GTPases Rac1 and Cdc42.
Hernández-Toledano DS; Vega L
Chem Biol Interact; 2023 Sep; 382():110593. PubMed ID: 37270087
[TBL] [Abstract][Full Text] [Related]
18. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
Guo F; Zheng Y
Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
[TBL] [Abstract][Full Text] [Related]
19. Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer.
Ma J; Xue Y; Liu W; Yue C; Bi F; Xu J; Zhang J; Li Y; Zhong C; Chen Y
PLoS One; 2013; 8(6):e66275. PubMed ID: 23750283
[TBL] [Abstract][Full Text] [Related]
20. Different roles of the small GTPases Rac1, Cdc42, and RhoG in CALEB/NGC-induced dendritic tree complexity.
Schulz J; Franke K; Frick M; Schumacher S
J Neurochem; 2016 Oct; 139(1):26-39. PubMed ID: 27412363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
